Capital Bancorp Named 2020 Bank & Thrift Sm-All Star by Piper Sandler
ROCKVILLE, Md., Oct. 02, 2020 (GLOBE NEWSWIRE) — Capital Bancorp, Inc. (NASDAQ: CBNK), the holding company for Capital Bank, N.A. is pleased to […]
The Pennant Group Acquires Nevada Hospice Agency
EAGLE, Idaho, Oct. 02, 2020 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant […]
Otonomy Completes Patient Enrollment for Phase 3 Trial of OTIVIDEX® in Ménière’s Disease
SAN DIEGO, Oct. 02, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative […]
Cytokinetics Announces Publication of Manuscript Detailing Baseline Characteristics of GALACTIC-HF in European Journal of Heart Failure
Heart Failure Patients in Phase 3 Clinical Trial of Omecamtiv Mecarbil Are at High Risk of Cardiovascular Events and Symptom […]
Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 4th Annual Genetic Medicines Conference
CAMBRIDGE, Mass., Oct. 02, 2020 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing […]
Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System
HAUPPAUGE, N.Y., Oct. 02, 2020 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious […]
Tiziana Life Sciences Plc (the “Company”) – Result of General Meeting
LONDON, Oct. 02, 2020 (GLOBE NEWSWIRE) — At the General Meeting of the Company (Nasdaq: TLSA / AIM: TILS) held at […]
CareDx Announces Publication of Pivotal AlloSure Lung Data
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]
Plus Therapeutics Announces Brain Cancer Clinical Advisory Team
AUSTIN, Texas, Oct. 02, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced the appointment of five […]
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
HANOVER, MD, Oct. 02, 2020 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (OTCQB: PCSA; Nasdaq: PCSA), a clinical-stage biopharmaceutical company focused […]
